logo
Select company
Select metric
$ -157.49MEarnings Before Interest Taxes & Depreciation Amortization (EBITDA)
VS
Market
5
Sector
12
Industry
17
History
-
$ 2.44Close
$ 0.73 - $ 2.79 52-Week Range
Ticker Information

Ticker

CRBU

Company Name

CARIBOU BIOSCIENCES INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

CARIBOU BIOSCIENCES INC - Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

CRBU - EBITDA Historical data
DateDepreciation, Amortization & AccretionEarning Before Interest & Taxes (EBIT)Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)
6/30/2025$ 6.78M$ -164.27M$ -157.49M
3/31/2025$ 6.52M$ -147.87M$ -141.35M
12/31/2024$ 6.1M$ -149.11M$ -143.01M
9/30/2024$ 5.67M$ -147.93M$ -142.26M
6/30/2024$ 5.96M$ -123.25M$ -117.29M
3/31/2024$ 5.7M$ -115.07M$ -109.36M
12/31/2023$ 5.57M$ -101.88M$ -96.3M
9/30/2023$ 5.24M$ -94.48M$ -89.25M
6/30/2023$ 4.21M$ -111.13M$ -106.92M
3/31/2023$ 3.94M$ -108.31M$ -104.37M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • CARIBOU BIOSCIENCES INC's latest trailing twelve months (TTM) EBITDA stands at $ -35.21M.
  • Over the past 5 years, CARIBOU BIOSCIENCES INC's average EBITDA has been $ -102.84M.
  • The median EBITDA for CARIBOU BIOSCIENCES INC during this period was $ -100.34M
  • CARIBOU BIOSCIENCES INC reached its highest EBITDA over the past 5 years at $ -35.21M.
  • The lowest EBITDA recorded by CARIBOU BIOSCIENCES INC in the same timeframe $ -157.49M

CARIBOU BIOSCIENCES INC's EBITDA vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

EBITDA Benchmarks
CompanyEBITDA
KRRO : KORRO BIO INC $ -85.36MTVRD : TVARDI THERAPEUTICS INC $ -13.45MTCRX : TSCAN THERAPEUTICS INC $ -130.55MACOG : ALPHA COGNITION INC $ -19.86MCRVO : CERVOMED INC $ -22.61MFATE : FATE THERAPEUTICS INC $ -155.49MOVID : OVID THERAPEUTICS INC $ -36.47MOBIO : ORCHESTRA BIOMED HOLDINGS INC $ -68.61MVERU : VERU INC $ -31.9MCBUS : CIBUS INC $ -234.61M

Similar metrics to EBITDA:

Definition of Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

[Calculation] EBITDA is a non-GAAP accounting metric that lets investors asses profitability net of expenses dependent on financing decision, tax strategy and depreciation schedules. It is calculated by adding depreciation and amortisation expenses [DepAmor] back to [EBIT].
EBIT + DepAmor
(=) EBITDA EBITDA for CARIBOU BIOSCIENCES INC is calculated as follows: EBIT [ $ -36.11M ] + DepAmor [ $ 900K ]
(=) EBITDA [ $ -35.21M ]

CRBU - Earnings Before Interest Taxes & Depreciation Amortization (EBITDA), Last 5 years

$ -157.49M

Minimum

Jun 30, 2025

$ -35.21M

Maximum

Dec 31, 2020

$ -102.84M

Average

$ -100.34M

Median

EBITDA Benchmark Analysis

 The chart above depicts the distribution of EBITDA for companies in the Total Stock Market. The average EBITDA of the companies is $ 58.87M with a standard deviation of $ 166.99M.
The following table provides additional summary stats:
EBITDA in the Market:
filtered constituents3.24K
min$ -493.3M
max$ 590.6M
average$ 58.87M
median$ 8.87M
std$ 166.99M